Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. The Company's Aethlon ADAPT platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT product pipeline includes the Hemopurifier, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as HIV and Hepatitis C.